Pharmaceutical News

New Treatment Option Available for Relapsed Multiple Myeloma in Scotland

/ June 17, 2026

Johnson & Johnson has announced that Talvey (also known as talquetamab) has been approved by the Scottish Medicines Consortium (SMC) […]

/ June 16, 2026

Connecta Therapeutics has started a new clinical trial (Phase IIa) for a drug called CTH120. This drug is designed to

/ June 15, 2026

A recent study published in the journal *Measurement Science and Technology* has found that moisture condensation on Petri dish lids

/ June 14, 2026

A new migraine treatment called Aquipta (atogepant) has been approved by the National Institute for Health and Care Excellence (NICE)

/ June 13, 2026

The UK’s medicines regulator, the Medicines and Healthcare products Regulatory Agency (MHRA), is starting a new program using artificial intelligence

/ June 12, 2026

A Swedish biotech company called Anocca has started the first tests in humans of a new experimental cancer treatment called

/ June 10, 2026

Johnson & Johnson recently shared early results from a clinical trial (called the JASMINE study) that tested a new medication

/ June 9, 2026

A recent court decision in the United States has forced Japanese drugmaker Takeda to report a significant financial loss for

/ June 8, 2026

A recent clinical trial for Zynlonta, a medication used to treat a type of blood cancer called diffuse large B-cell

/ June 7, 2026

A pharmaceutical company called Axsome Therapeutics has reached a legal agreement that will prevent other companies from selling cheaper, generic